2017-11-14T12:50:29-05:00 2016-12-31 042666565 John M Monticone CPA 5 High Street Suite 207 Medford MA 02155 990 2016-01-01 043333682 BEDFORD RESEARCH FOUNDATION BEDF 53 CONCORD ROAD BEDFORD MA 01730 Ann Kiessling President 6176235670 2017-05-04 true John M Monticone CPA P01257043 7813950024 2017-11-14 X 98.217.9.124 2017-11-15 10:28:27 0404342017319zcm1cl4 2017-11-15 P 3F32101032E160E6A2CA19266E00DF59511B13FC 3F32101032E160E6A2CA19266E00DF59511B13FC 2016 2017-02-10 21:41:12Z Ann Kiessling 650409 false X WWW.BEDFORDRESEARCH.ORG X 1996 MA Stem cell research, prostate disease research and HIV Research. 15 14 9 15 0 0 51746 45564 642511 568409 9664 8318 0 703921 622291 4500 0 0 240805 234286 0 14548 366825 293025 612130 527311 91791 94980 482585 622980 26952 45087 455633 577893 Stem cell research, prostate disease research and HIV Research. false false 455460 568409 Special program of Assisted Reproduction takes advantage of Assited Reproduction Technology procedures to assist couples achieve a pregnancy who would otherwise risk transmitting the fathers infection to the mother and the child through intercourse. During this process, researches gathered information to prevent the transmission of sexually transmitted deseases. HIV Research. 455460 true true false false false false false false false true true true false false false true true false false false false false false false false false false false false false false false false true false false false true false false false false false false false false false false true 2 0 9 true false false false false false false false false false false false false false false false X 15 14 false false false false false false false true false false false true true true false true true true false false MA X X Ann Kiessling 6176235670 53 CONCORD ROAD BEDFORD MA 01730 Ann Kiessling President 40.00 0.00 X X 66000 0 0 Alan Geismer Chairman 0.30 0.00 X X 0 0 0 John Lee Secretary 0.30 0.00 X 0 0 0 Larry LaFranchi Treasurer 1.00 0.00 X X 0 0 0 Alan Mayer Director 0.30 0.00 X 0 0 0 Anil Purohit Director 0.30 0.00 X 0 0 0 Ellen Sheehy Director 0.30 0.00 X 0 0 0 Jose Cibelli Director 0.30 0.00 X 0 0 0 Margaret Wray Director 0.30 0.00 X 0 0 0 Robert Kaufmann Director 0.30 0.00 X 0 0 0 Scott Anderson Director 0.30 0.00 X 0 0 0 Susan Moss Director 0.30 0.00 X 0 0 0 Victoria Staebler Director 0.30 0.00 X 0 0 0 Yael Schwartz Director 0.30 0.00 X 0 0 0 Loch Jones Director 0.30 0.00 X 0 0 0 Sean Kealy Director 0.30 0.00 X 0 0 0 66000 0 0 0 false false false 45564 45564 Assisted reproduction 621500 568409 568409 568409 9013 9013 27423 28118 -695 -695 -695 622291 568409 0 8318 66000 52800 9900 3300 146944 128232 15203 3509 3273 2782 386 105 18069 15361 2130 578 23 23 3250 3250 11691 10441 1250 1512 1512 15050 4432 10618 81848 72845 6548 2455 6733 5655 539 539 1475 1475 14357 14357 3979 3383 469 127 Telephone 7699 5774 1540 385 Postages 9594 3198 3198 3198 Donor and Lab supplies 117915 117915 Repairs and maintenance 7031 5273 1406 352 10868 10025 843 527311 455460 57303 14548 132196 191243 35499 111754 19258 5595 24406 4000 167726 147007 35076 20719 57095 149036 197005 104227 6456 12000 482585 622980 7499 32792 19453 12295 26952 45087 X 455633 577893 455633 577893 482585 622980 94980 27280 0 X X false true X true false X 78350 56857 144391 51746 45564 376908 337646 413572 497135 642511 568409 2459273 415996 470429 641526 694257 613973 2836181 25000 20000 12500 10000 67500 25000 20000 12500 10000 67500 2768681 9234 5000 15021 9664 8318 47237 9234 5000 15021 9664 8318 47237 425230 475429 656547 703921 622291 2883418 0.96020 0.94870 0.02000 0.02000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13600 13600 4500 5000 9500 24100 19600 4500 10000 12000 22000 17000 15000 22000 10000 false false 29529 24608 4921 138197 122399 15798 20719 400 shares Coca-Cola Com 33168 F 500 shares Merk and Co 29435 F 400 shares Prudential Financial 41624 F 104227 Security Deposit 12000 12000 X 649571 27280 27280 622291 622291 527311 527311 527311 Footnote for uncertain tax position under FIN 48 (Part X) The Organization currently evaluates all tax positions, and makes a determination regarding the likelihood of those positions being upheld under review. The primary tax positions made by the Organization are the existence of unrelated business income tax and the Organizations status as a Tax-exempt Organization under Section 501(c)(3) of the Internal Revenue Code. For the years presented, the Organization has not recognized any tax benefits or loss contingencies for uncertain tax positions based on this evaluation. All tax periods prior to fiscal year ended December 31, 2013 are no longer subject to examination by tax authorities. Dr Ann Kiessling PresidentExec Direc See supplemental inf X 24406 24406 false true true 24406 Dr Ann Kiessling PresidentExecDirector 20000 See supplemental information false Supplemental Information for Schedule L PART II - LOANS TO INTERESTED PERSON:Oct October 3, 2016, the Organization provided an unsecured loan to the President of the Organization. The outstanding principal amount of $24,406 was paid in full as November 6, 2017. This loan was provided to fund the purchase of a building rented by the Organization from unrelated third party. PART IV - BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS:The Organization has signed a five year lease for office space with a for profit entity, which is owned by the President and board member of the Organization. The lease calls for monthly base rent of $4,000. For the year 2016, the Organization paid $8,000 to the related party, which represents $4,000 for December 2016 and $4,000 for January 2017. In addition, the Organization paid $12,000 to the related party for Security Deposit and last month rent. Officer directors etc family relationship Part VI line 2 xxxxxxx Committee meeting documentation Part VI line 8b No committee has the authority to act on behalf of the governing body. Form 990 governing body review Part VI line 11 Two weeks before filing the 990 form, a copy is given to each board of directors for review and discussion. Conflict of interest policy compliance Part VI line 12c The organization requires each new key employee, officer or director to review a copy of the Policy on Conflict of Interest and Disclosure of Certain Interests and to acknowledge in writing that he or she has done so. Additionally, each key employee, officer or director, annually complete a disclosure form identifying any relationships, positions or circumstances in which the employee is involved that he or she believes could contribute to a conflict of interest arising. CEO executive director top management comp Part VI line 15a The board of directors establishes the compensation for the Executive Director that are within the range or organizations similar in size and scope of Bedford Research Foundation. Governing documents etc available to public Part VI line 19 Copy of the financial statements and current year changes in the governing documents, conflict of interest policy are attached to the PC Form which is filed in the Secretary of State and available for public inspection. Also, copy of these documents are available at the organizations office at 53 Concord Road, Bedford, MA 01730, for public inspection upon request. Audited by an independent accountant Part XII line 2b The Organizations President and Treasurer have the responsibility to oversight the Review and the selection of the independent accountant. Cessation of or significant change to any program service Part III line 3 The Organization ceased conducting the Post-Vasectomy Test: The level of activity of this program and the resouces needed to continue the program were considered not material by the board of directors and the organization could provide greater good to the general public by expending those resources into the main program. Prior to 2015, as disclosed on the 2014 990 Tax Form, the Organization provided services to a related organization during prior years. The sole proprietor of this related organization was also the President of Bedford Research Foundation. Explanation of other changes in net assets or fund balances Part XI line 9 Market Value appreciation of investments